BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
Copyright: ©Author(s) 2026.
World J Psychiatry. May 19, 2026; 16(5): 116997
Published online May 19, 2026. doi: 10.5498/wjp.v16.i5.116997
Table 1 Comparison of general baseline characteristics between the two groups
Item
Control (n = 64)
Study (n = 64)
Statistic
P value
Sex (male/female)38/2636/28χ2 = 0.1270.722
Age (years)53.4 ± 4.553.8 ± 5.2t = -0.4780.633
Dry weight (kg)58.3 ± 6.957.8 ± 7.2t = 0.4080.684
Dialysis vintage (months)38.2 ± 12.636.9 ± 11.8t = 0.5980.551
Residual urine volume (mL/24 hours)245.6 ± 85.3238.4 ± 79.7t = 0.5020.616
Table 2 Comparison of Self-Rating Anxiety Scale scores and Self-Rating Depression Scale scores of the two groups of patients before and after nursing intervention
Group
n
SAS score
SDS score
Before the intervention
After the intervention
Before the intervention
After the intervention
Control group6438.25 ± 6.2529.00 ± 5.10a36.33 ± 4.8526.96 ± 4.28a
Study group6438.28 ± 6.3418.56 ± 5.08a35.35 ± 4.7415.40 ± 4.36a
t value0.0311.841.1611.56
P value0.9800.0010.2490.001
Table 3 Comparison of World Health Organization Quality of Life-BREF scores of the two groups of patients before and after treatment
Group
n
Physical health
Mental health
Social relations
Environment
Before the intervention
After the intervention
Before the intervention
After the intervention
Before the intervention
After the intervention
Before the intervention
After the intervention
Control group649.13 ± 2.1011.16 ± 2.18a10.96 ± 2.4412.87 ± 2.27a12.37 ± 2.3713.56 ± 2.41a13.10 ± 2.1915.46 ± 2.15a
Study group648.98 ± 2.3112.57 ± 3.02a11.07 ± 2.5314.46 ± 2.32a12.40 ± 3.0514.85 ± 2.33a13.22 ± 2.4416.97 ± 1.88a
t value0.2853.8120.434.7680.6453.0780.8985.837
P value0.768< 0.0010.658< 0.0010.5210.0010.38< 0.001
Table 4 Comparison of Kidney Disease Quality of Life scores before and after intervention in the two groups of patients
Groupn
General health conditions
Specific areas of kidney diseases
Before the intervention
After the intervention
t value
P value
Before the intervention
After the intervention
t value
P value
Control group6465.47 ± 10.2168.23 ± 9.684.497< 0.00160.27 ± 9.7463.59 ± 10.3714.034< 0.001
Study group6466.21 ± 9.561.25 ± 10.1010.657< 0.00160.30 ± 10.3268.35 ± 9.8729.152< 0.001
t value0.4953.2140.4953.214
P value0.6320.0230.6320.023
Table 5 Comparison of the incidence of complications during treatment between the two groups of patients, n (%)
Group
n
Infection
Hypertension
Hypotension complications
Anemia
Control group644 (6.25)24 (37.5)27 (42.18)9 (14.06)
Study group642 (3.13)15 (23.44)16 (25.00)2 (3.12)
χ2 value0.1743.1254.1264.873
P value0.4050.0470.0420.028


Write to the Help Desk